| scholarly article | Q13442814 |
| P2093 | author name string | Feng Liu | |
| Yongjun Wang | |||
| Qiang Fu | |||
| Dun Wang | |||
| Jingling Tang | |||
| Kelly Racette | |||
| P2860 | cites work | Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 |
| Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion | Q28366592 | ||
| Targeting multidrug resistance in cancer | Q29616803 | ||
| Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29620308 | ||
| Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). | Q30729351 | ||
| Biochemical, cellular, and pharmacological aspects of the multidrug transporter | Q33636699 | ||
| Pharmacological strategies for overcoming multidrug resistance | Q33997660 | ||
| Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel | Q34005908 | ||
| Multidrug resistance transporters and modulation | Q34024504 | ||
| Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs | Q34060806 | ||
| Vitamin E TPGS as a molecular biomaterial for drug delivery | Q34267893 | ||
| The role of half-transporters in multidrug resistance | Q34502464 | ||
| Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. | Q34761824 | ||
| Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. | Q35048763 | ||
| Effective drug delivery by PEGylated drug conjugates | Q35058925 | ||
| Vitamins E and C are safe across a broad range of intakes | Q36092321 | ||
| Antinociceptive effects of intraperitoneal and intrathecal vitamin e in the rat formalin test | Q36310253 | ||
| Does vitamin E prevent or promote cancer? | Q36411304 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Paclitaxel nanocrystals for overcoming multidrug resistance in cancer | Q36623275 | ||
| Effect of pluronic P85 on ATPase activity of drug efflux transporters | Q37179672 | ||
| Three decades of P-gp inhibitors: skimming through several generations and scaffolds. | Q37976863 | ||
| The effect of nanoparticle size, shape, and surface chemistry on biological systems | Q38004588 | ||
| Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells | Q39564806 | ||
| Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy | Q39728536 | ||
| Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited | Q39911958 | ||
| Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines | Q40487755 | ||
| Pumping of Drugs by P-Glycoprotein: A Two-Step Process? | Q40627950 | ||
| Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines | Q40645005 | ||
| A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro | Q40706801 | ||
| A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein | Q40730733 | ||
| Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities. | Q40977097 | ||
| Promotion of microtubule assembly in vitro by taxol | Q41461193 | ||
| Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). | Q41701150 | ||
| Understanding the structure and stability of paclitaxel nanocrystals | Q41884506 | ||
| Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications | Q42175440 | ||
| Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. | Q43768000 | ||
| Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers | Q44123431 | ||
| Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo | Q46487609 | ||
| Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers | Q46892593 | ||
| Extraction Issues of Paclitaxel in Nanocrystals | Q47606307 | ||
| Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450. | Q47799418 | ||
| Vitamin E: action, metabolism and perspectives | Q56038941 | ||
| Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil | Q70721995 | ||
| Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults | Q72760013 | ||
| High levels of dietary vitamin E do not replace cellular glutathione peroxidase in protecting mice from acute oxidative stress | Q73128267 | ||
| Cancer multidrug resistance | Q73548512 | ||
| Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity | Q79969109 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 149-157 | |
| P577 | publication date | 2013-04-23 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Vitamin E reverses multidrug resistance in vitro and in vivo | |
| P478 | volume | 336 |
| Q34089249 | Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer |
| Q92493643 | Current Applications of Nanoemulsions in Cancer Therapeutics |
| Q35994325 | D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery |
| Q90540568 | Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue |
| Q38990892 | FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1. |
| Q90429639 | Machine Learning Uncovers Food- and Excipient-Drug Interactions |
| Q37013374 | Molecular-matched materials for anticancer drug delivery and imaging |
| Q95840240 | Nanoparticle delivery of a pH-sensitive prodrug of doxorubicin and a mitochondrial targeting VES-H8R8 synergistically kill multi-drug resistant breast cancer cells |
| Q47164896 | Recent Advances in the Application of Vitamin E TPGS for Drug Delivery |
| Q47814018 | Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy |
| Q50852004 | Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer. |
| Q88404555 | Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles |
| Q37594151 | Solid lipid nanoparticles with TPGS and Brij 78: A co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro |
| Q48147687 | The antitumor efficacy of docetaxel is enhanced by encapsulation in novel amphiphilic polymer cholesterol-coupled tocopheryl polyethylene glycol 1000 succinate micelles |
| Q38977484 | Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging. |
| Q58117277 | VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer |
| Q38808499 | Vitamin E derivative-based multifunctional nanoemulsions for overcoming multidrug resistance in cancer |
| Q34451618 | Vitamin E transporters in cancer therapy |
| Q59796214 | pH-Sensitive Poly(β-amino ester)s Nanocarriers Facilitate the Inhibition of Drug Resistance in Breast Cancer Cells |
Search more.